KarXT by Karuna Therapeutics offers hope for improved schizophrenia management
HQ Team, December 18, 2023: For individuals grappling with schizophrenia, the road to treatment is often marked by a lifelong commitment to antipsychotic
HQ Team, December 18, 2023: For individuals grappling with schizophrenia, the road to treatment is often marked by a lifelong commitment to antipsychotic
HQ Team December 18, 2023: Investigative results from a pilot study showed that those with burnt-out diabetes and end-stage kidney disease experienced a
HQ Team December 15, 2023: Teenagers are using e-cigarettes at a rate higher than adults, and in England, the numbers have tripled in
HQ Team December 15, 2023: Merck announced it got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form
HQ Team December 15, 2023: A new vaccine to aid the human body’s white cells to fight HIV infection may hold the key
HQ Team December 13, 2023: Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of
HQ Team December 13, 2023: Vertex Pharmaceuticals, a US-based biotechnology company, announced its mid-stage trial on a non-opioid oral drug for patients with
HQ Team December 13, 2023: Japan’s Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan
HQ Team December 13, 2023: The UN climate conference has called for a “transitioning away” from fossil fuels to cut greenhouse gas emissions
HQ Team December 13, 2023: Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring